Molecular Therapy-Oncolytics

Article	Citations
Retraction Notice to: miR-140-3p Inhibits Cutaneous Melanoma Progression by Disrupting AKT/p70S6K and JNK Pathways through ABHD2	113
RETRACTED: Comprehensive analysis of FKBP4/NR3C1/TMEM173 signaling pathway in triple-negative breast cancer cell and dendritic cell among tumor microenvironment	89
Promoting role of pentraxin-3 in esophageal squamous cell carcinoma	88
LINC01296 promotes neuroblastoma tumorigenesis via the NCL-SOX11 regulatory complex	84
Extracellular vesicle contents as non-invasive biomarkers in ovarian malignancies	70
Azelnidipine inhibits esophageal squamous cell carcinoma proliferation in vivo and in vitro by targeting MEK1/2	69
Radiovirotherapy at twenty	61
Dynamic fine-tuning of CAR-T cell therapy	60
Neoadjuvant use of oncolytic herpes virus G47Δ prevents local recurrence after insufficient resection in tongue cancer models	55
Thank you to our 2022 reviewers	52
Upregulation of endogenous TRAIL-elicited apoptosis is essential for metformin-mediated antitumor activity against TNBC and NSCLC	52
R. Daniel Beauchamp (1946–2022)	52
Single-cell transcriptomics reveal DHX9 in mature B cell as a dynamic network biomarker before lymph node metastasis in CRC	51
hnRNPK-derived cell-penetrating peptide inhibits cancer cell survival	49
Sperm protein 17 targeting for epithelial ovarian cancer treatment in the era of modern immunoengineering	46
NEBL and AKT1 maybe new targets to eliminate the colorectal cancer cells resistance to oncolytic effect of vesicular stomatitis virus M-protein	45
The next wave of cellular immunotherapies in pancreatic cancer	44
esRAGE-expressing oHSV enhances anti-tumor efficacy by inhibition of endothelial cell activation	44
Lentiviral interferon: A novel method for gene therapy in bladder cancer	44
A PD1 targeted nano-delivery system based on epigenetic alterations of T cell responses in the treatment of gastric cancer	42
Ferroptosis gene signature in cholangiocarcinoma	41
Claudin18.2 bispecific T cell engager armed oncolytic virus enhances antitumor effects against pancreatic cancer	41
Metabolic remodeling in tumor-associated macrophages contributing to antitumor activity of cryptotanshinone by regulating TRAF6-ASK1 axis	41
Next generation oncolytic viruses expressing PADI1 and TIMP2 exhibit anti-tumor activity against melanoma in nude and humanized mouse models	39
Efficacy of a third-generation oncolytic herpes simplex virus in refractory soft tissue sarcoma xenograft models	38

The tRNA-derived fragment signature in lung cancer	38
Tumor immune microenvironment-based classifications of bladder cancer for enhancing the response rate of immunotherapy	38
TRIM22 orchestrates the proliferation of GBMs and the benefits of TMZ by coordinating the modification and degradation of RIG-I	36
Human lung adenocarcinoma CD47 is upregulated by interferon-γ and promotes tumor metastasis	35
Involvement of actin cytoskeletal modifications in the inhibition of triple-negative breast cancer growth and metastasis by nimbolide	35
Combining vanadyl sulfate with Newcastle disease virus potentiates rapid innate immune-mediated regression with curative potential in murine cancer models	35
LRPPRC regulates metastasis and glycolysis by modulating autophagy and the ROS/HIF1-α pathway in retinoblastoma	34
PET imaging and treatment of pancreatic cancer peritoneal carcinomatosis after subcutaneous intratumoral administration of a novel oncolytic virus, CF33-hNIS-antiPDL1	33
Lazertinib improves the efficacy of chemotherapeutic drugs in ABCB1 or ABCG2 overexpression cancer cells in vitro, in vivo, and ex vivo	33
A novel CD34-derived hinge for rapid and efficient detection and enrichment of CAR T cells	33
Combination of a STAT3 inhibitor with anti-PD-1 immunotherapy is an effective treatment regimen for a vemurafenib-resistant melanoma	32
Oncolytic virotherapy with intratumoral injection of vaccinia virus TG6002 and 5-fluorocytosine administration in dogs with malignant tumors	32
Oncolytic Zika virus promotes intratumoral T cell infiltration and improves immunotherapy efficacy in glioblastoma	32
Polycytidine tract deletion from microRNA-detargeted oncolytic Mengovirus optimizes the therapeutic index in a murine multiple myeloma model	31
Characterization and quantitation of busulfan DNA adducts in the blood of patients receiving busulfan therapy	31
MicroRNA-sensitive oncolytic measles virus for chemovirotherapy of pancreatic cancer	30
Targeting carcinoembryonic antigen-expressing tumors using a novel transcriptional and translational dual-regulated oncolytic herpes simplex virus type 1	29
Bacterial cancer therapy using the attenuated fowl-adapted Salmonella enterica serovar Gallinarum	29
Expanding the landscape of TCR gene therapy targeting MAGE	28
Pre-treatment with systemic agents for advanced NSCLC elicits changes in the phenotype of autologous T cell therapy products	28
Isolation of TCR genes with tumor-killing activity from tumor-infiltrating and circulating lymphocytes in a tumor rejection cynomolgus macaque model	28
SNHG1 knockdown upregulates miR-376a and downregulates FOXK1/Snail axis to prevent tumor growth and metastasis in HCC	28
Intratumoral delivery of a novel oncolytic adenovirus encoding human antibody against PD-1 elicits enhanced antitumor efficacy	28
miR-19a/b promote EMT and proliferation in glioma cells via SEPT7-AKT-NF-κB pathway	27
Engineered CAR-T cells targeting TAG-72 and CD47 in ovarian cancer	27
Dual EGFR- and TfR-targeted gene transfer for sodium iodide symporter gene therapy of glioblastoma	27
microRNA-130b-3p contained in MSC-derived EVs promotes lung cancer progression by regulating the FOXO3/NFE2L2/TXNRD1 axis	27
Dual blockade of CD47 and CD24 signaling using a novel bispecific antibody fusion protein enhances macrophage immunotherapy	26
circBANP promotes colorectal cancer growth and metastasis via sponging let-7d-5p to modulate HMGA1/Wnt/β-catenin signaling	26
Nanobody-based retargeting of an oncolytic herpesvirus for eliminating CXCR4+ GBM cells: A proof of principle	25
A novel TanCAR targeting IL13Rα2 and EphA2 for enhanced glioblastoma therapy	25
Spatiotemporal analysis of induced neural stem cell therapy to overcome advanced glioblastoma recurrence	25
Regulation of CD19 CAR-T cell activation based on an engineered downstream transcription factor	25
Transgenic viral expression of PH-20, IL-12, and sPD1-Fc enhances immune cell infiltration and anti-tumor efficacy of an oncolytic virus	24
The emerging role of off-the-shelf engineered natural killer cells in targeted cancer immunotherapy	24
PTOV1 promotes cisplatin-induced chemotherapy resistance by activating the nuclear factor kappa B pathway in ovarian cancer	23
Deletion of immunomodulatory genes as a novel approach to oncolytic vaccinia virus development	22
Adding recombinant AAVs to the cancer therapeutics mix	22
DNA-methylation-induced silencing of DIO3OS drives non-small cell lung cancer progression via activating hnRNPK-MYC-CDC25A axis	22
Improved lentiviral vector titers from a multi-gene knockout packaging line	22
Oncogenic lncRNA BBOX1-AS1 promotes PHF8-mediated autophagy and elicits sorafenib resistance in hepatocellular carcinoma	22
Regulatory role and mechanism of m6A RNA modification in human metabolic diseases	22
Icaritin inhibits PLK1 to activate DNA damage response in NK/T cell lymphoma and increases sensitivity to GELOX regime	22
Oncolytic vaccinia virus injected intravenously sensitizes pancreatic neuroendocrine tumors and metastases to immune checkpoint blockade	22
Narciclasine targets STAT3 via distinct mechanisms in tamoxifen-resistant breast cancer cells	21
MicroRNA modification of coxsackievirus B3 decreases its toxicity, while retaining oncolytic potency against lung cancer	21
Nucleic acids and proteins carried by exosomes of different origins as potential biomarkers for gynecologic cancers	21
Novel roles of METTL1/WDR4 in tumor via m7G methylation	21
Vorolanib, a novel tyrosine receptor kinase receptor inhibitor with potent preclinical anti-angiogenic and anti-tumor activity	21
Synthetic mRNA-based gene therapy for glioblastoma: TRAIL-mRNA synergistically enhances PTEN-mRNA-based therapy	20

PBX3-activated DLG1-AS1 can promote the proliferation, invasion, and migration of TNBC cells by sponging miR-16-5p	20
Novel two-chain structure utilizing KIRS2/DAP12 domain improves the safety and efficacy of CAR-T cells in adults with r/r B-ALL	20
Metformin preferentially enhances the radio-sensitivity of cancer stem-like cells with highly mitochondrial respiration ability in HMPOS	20
Systematic profiling of ferroptosis gene signatures predicts prognostic factors in esophageal squamous cell carcinoma	20
Zika virus cleaves GSDMD to disseminate prognosticable and controllable oncolysis in a human glioblastoma cell model	20
Efficacy and safety of a third-generation oncolytic herpes virus G47Δ in models of human esophageal carcinoma	20
Transcriptional landscape associated with TNBC resistance to neoadjuvant chemotherapy revealed by single-cell RNA-seq	20
Therapeutically targeting oncogenic CRCs facilitates induced differentiation of NB by RA and the BET bromodomain inhibitor	20
lncRNA MIR503HG inhibits cell proliferation and promotes apoptosis in TNBC cells via the miR-224-5p/HOXA9 axis	19
Reprogramming the tumor microenvironment leverages CD8+ T cell responses to a shared tumor/self antigen in ovarian cancer	19
LINC00461 facilitates HNSCC development and reduces chemosensitivity by impairing miR-195-mediated inhibition of HOXA10	19
Reinvigoration of innate and adaptive immunity via therapeutic cellular vaccine for patients with AML	19
Nuclear export protein CSE1L interacts with P65 and promotes NSCLC growth via NF-κB/MAPK pathway	19
RHAMMB-mediated bifunctional nanotherapy targeting Bcl-xL and mitochondria for pancreatic neuroendocrine tumor treatment	19
Single-cell RNA-sequencing analyses identify heterogeneity of CD8+ T cell subpopulations and novel therapy targets in melanoma	19
Quantitative proteomics characterization of cancer biomarkers and treatment	19
m6A methyltransferase METTL3-mediated lncRNA FOXD2-AS1 promotes the tumorigenesis of cervical cancer	19
Palmitoylated antigens for the induction of anti-tumor CD8+ T cells and enhanced tumor recognition	19
Thank you to our 2021 reviewers	18
The quest for effective immunotherapies against malignant peripheral nerve sheath tumors: Is there hope?	18
Chandipura virus induces cell death in cancer cell lines of human origin and promotes tumor regression in vivo	18
Oncolytic adenovirus for treatment of malignant ascites	18
A polygenic methylation prediction model associated with response to chemotherapy in epithelial ovarian cancer	18
Therapeutic effects of TM4SF5-targeting chimeric and humanized monoclonal antibodies in hepatocellular and colon cancer models	18
Treatment of glioblastoma with current oHSV variants reveals differences in efficacy and immune cell recruitment	18
A novel anti-B7-H3 chimeric antigen receptor from a single-chain antibody library for immunotherapy of solid cancers	18
Oncolytic virotherapy targeting the IL15 pathway	17
miR-146a: Overcoming coldness in ovarian cancer	17
Interleukin-6-controlled, mesenchymal stem cell-based sodium/iodide symporter gene therapy improves survival of glioblastoma-bearing mice	17
PTEN potentiation of oncolytic HSV therapy for glioblastoma	17
HKI-272 contributes to gemcitabine-mediated anti-proliferative and anti-metastatic effects through EGFR suppression in gallbladder cancer	17
Upregulation of deubiquitinase USP7 by transcription factor FOXO6 promotes EC progression via targeting the JMJD3/CLU axis	17
Seneca Valley virus replicons are packaged in trans and have the capacity to overcome the limitations of viral transgene expression	17
Treatment with the PPARα agonist fenofibrate improves the efficacy of CD8+ T cell therapy for melanoma	16
miR-301 regulates the SIRT1/SOX2 pathway via CPEB1 in the breast cancer progression	16
Enhanced tumor targeting and timely viral release of mesenchymal stem cells/oncolytic virus complex due to GRP78 and inducible E1B55K expressions greatly increase the antitumor effect of systemic trea	16
Ubiquitin-related molecular classification and risk stratification of hepatocellular carcinoma	16
Knockdown of SENP1 inhibits HIF-1α SUMOylation and suppresses oncogenic CCNE1 in Wilms tumor	15
Development of a 5-FU modified miR-129 mimic as a therapeutic for non-small cell lung cancer	15
Oncolytic reovirus-mediated recruitment of early innate immune responses reverses immunotherapy resistance in prostate tumors	15
Modulation of mTOR and epigenetic pathways as therapeutics in gallbladder cancer	15
β2-Adrenergic receptor agonist enhances the bystander effect of HSV-TK/GCV gene therapy in glioblastoma multiforme via upregulation of connexin 43 expression	15
Expanding the role of interventional oncology for advancing precision immunotherapy of solid tumors	15
IRGM promotes melanoma cell survival through autophagy and is a promising prognostic biomarker for clinical application	15
miR-15a and miR-15b modulate natural killer and CD8+T-cell activation and anti-tumor immune response by targeting PD-L1 in neuroblastoma	15
Secretion of bispecific protein of anti-PD-1 fused with TGF-β trap enhances antitumor efficacy of CAR-T cell therapy	15
CD133 mRNA-transfected dendritic cells induce coordinated cytotoxic and helper T cell responses against breast cancer stem cells	15
Modulation of p53 expression in cancer-associated fibroblasts prevents peritoneal metastasis of gastric cancer	15
New advances in cancer therapy targeting TGF-β signaling pathways	15
A systematic analysis on the clinical safety and efficacy of onco-virotherapy	15
Oncolytic herpes virus G47Δ works synergistically with CTLA-4 inhibition via dynamic intratumoral immune modulation	15
A New Tool for CRISPR-Cas13a-Based Cancer Gene Therapy	14
Oncolytic vaccinia virus induces a novel phenotype of CD8+ effector T cells characterized by high ICOS expression	14
IFN-I-tolerant oncolytic Semliki Forest virus in combination with anti-PD1 enhances T cell response against mouse glioma	14
Efficacy of cancer-specific anti-podoplanin CAR-T cells and oncolytic herpes virus G47Δ combination therapy against glioblastoma	14
A host non-coding RNA, nc886, plays a pro-viral role by promoting virus trafficking to the nucleus	14
Polymer stealthing and mucin-1 retargeting for enhanced pharmacokinetics of an oncolytic vaccinia virus	14
Gene-edited and CAR-NK cells: Opportunities and challenges with engineering of NK cells for immunotherapy	14
The pivotal regulatory factor circBRWD1 inhibits arsenic exposure-induced lung cancer occurrence by binding mRNA and regulating its stability	14
Diversity in responses to oncolytic Lassa-vesicular stomatitis virus in patient-derived glioblastoma cells	14
MicroRNA-detargeting proves more effective than leader gene deletion for improving safety of oncolytic Mengovirus in a nude mouse model	14
Adoptive T cell immunotherapy for medullary thyroid carcinoma targeting GDNF family receptor alpha 4	13
Induction of cell death in ovarian cancer cells by doxorubicin and oncolytic vaccinia virus is associated with CREB3L1 activation	13
Applications of nuclear-based imaging in gene and cell therapy: Probe considerations	13
Infection of non-cancer cells: A barrier or support for oncolytic virotherapy?	13
ScRNA-seq and bulk RNA-seq reveal the characteristics of ferroptosis and establish a risk signature in cholangiocarcinoma	13
Enhancing the effectiveness of γδ T cells by mRNA transfection of chimeric antigen receptors or bispecific T cell engagers	13
Circular RNA circRAB31 acts as a miR-885-5p sponge to suppress gastric cancer progression via the PTEN/PI3K/AKT pathway	13
DAP10 integration in CAR-T cells enhances the killing of heterogeneous tumors by harnessing endogenous NKG2D	13
Targeting receptor tyrosine kinases in ovarian cancer: Genomic dysregulation, clinical evaluation of inhibitors, and potential for combinatorial therapies	13
Remission of liquid tumors and SARS-CoV-2 infection: A literature review	13
Molecular profiles of small cell lung cancer subtypes: Therapeutic implications	13
Anti-CAIX BBζ CAR4/8 T cells exhibit superior efficacy in a ccRCC mouse model	13
SEC coupled with in-line multiple detectors for the characterization of an oncolytic Coxsackievirus	13
The miR-23a/27a/24-2 cluster promotes postoperative progression of early-stage non-small cell lung cancer	12
MicroRNA-499 serves as a sensitizer for lung cancer cells to radiotherapy by inhibition of CK2α-mediated phosphorylation of p65	12
Eliminating mesothelioma by AAV-vectored, PD1-based vaccination in the tumor microenvironment	12
PROTACs in gastrointestinal cancers	12
Endogenous H3.3K27M derived peptide restricted to HLA-A∗02:01 is insufficient for immune-targeting in diffuse midline glioma	12
miR-519d-3p suppresses tumorigenicity and metastasis by inhibiting Bcl-w and HIF-1α in NSCLC	12

Circular RNA circLAMA3 inhibits the proliferation of bladder cancer by directly binding an mRNA	12
Natural killer cells and immune-checkpoint inhibitor therapy: Current knowledge and new challenges	12
Defueling the cancer: ATP synthase as an emerging target in cancer therapy	12
Potent anti-tumor effects of receptor-retargeted syncytial oncolytic herpes simplex virus	12
The long non-coding RNA SNHG4/microRNA-let-7e/KDM3A/p21 pathway is involved in the development of non-small cell lung cancer	12
Association of IDH mutation and 1p19q co-deletion with tumor immune microenvironment in lower-grade glioma	12
Nanobody-derived bispecific CAR-T cell therapy enhances the anti-tumor efficacy of T cell lymphoma treatment	12
Mechanisms of drug resistance in breast cancer liver metastases: Dilemmas and opportunities	12
Oncolytic virus-mediated p53 overexpression promotes immunogenic cell death and efficacy of PD-1 blockade in pancreatic cancer	12
Oncolytic activity of naturally attenuated herpes-simplex virus HF10 against an immunocompetent model of oral carcinoma	12
Acquired chemoresistance can lead to increased resistance of pancreatic cancer cells to oncolytic vesicular stomatitis virus	11
Trap and ambush therapy using sequential primary and tumor escape-selective oncolytic viruses	11
DNA-damaging cancer cells to improve virotherapy	11
Recombinant oncolytic adenovirus expressing a soluble PVR elicits long-term antitumor immune surveillance	11
Oncolytic viruses: Narcissistic or altruistic arsonists?	11
Non-coding RNAs and glioma: Focus on cancer stem cells	11
Attack of the clones: An NK cell origins story	11
Oncolytic herpes simplex virus armed with a bacterial GBP1 degrader improves antitumor activity	11
Anthony N. van den Pol (1949–2020)	11
Neoadjuvant systemic oncolytic vesicular stomatitis virus is safe and may enhance long-term survivorship in dogs with naturally occurring osteosarcoma	11
Cancer stem/progenitor signatures refine the classification of clear cell renal cell carcinoma with stratified prognosis and decreased immunotherapy efficacy	11
IFNAR blockade synergizes with oncolytic VSV to prevent virus-mediated PD-L1 expression and promote antitumor T cell activity	11
HDAC inhibition prevents transgene expression downregulation and loss-of-function in T cell-receptor-transduced T cells	10
Addition of BTK inhibitor orelabrutinib to rituximab improved anti-tumor effects in B cell lymphoma	10
Multiple targeted self-emulsifying compound RGO reveals obvious anti-tumor potential in hepatocellular carcinoma	10
Introducing a new reporter gene, membrane-anchored Cypridina luciferase, for multiplex bioluminescence imaging	10
Novel insights into circular RNA regulation in arsenic-exposure-induced lung cancer	10
TTN-AS1 accelerates the growth and migration of nasopharyngeal carcinoma cells via targeting miR-876-5p/NETO2	10
lncRNA RP11-147L13.8 suppresses metastasis and chemo-resistance by modulating the phosphorylation of c-Jun protein in GBC	10
Thank you to our 2023 reviewers	10
Beyond ENO1, emerging roles and targeting strategies of other enolases in cancers	10
An oral cancer vaccine using a Bifidobacterium vector suppresses tumor growth in a syngeneic mouse bladder cancer model	10
Targeting EGFR sensitizes 5-Fu-resistant colon cancer cells through modification of the lncRNA-FGD5-AS1-miR-330-3p-Hexokinase 2 axis	10
Physiological lentiviral vectors for the generation of improved CAR-T cells	10
Exosomal circSHKBP1 participates in non-small cell lung cancer progression through PKM2-mediated glycolysis	10
Cholesterol-enriched membrane micro-domain deficiency induces doxorubicin resistance via promoting autophagy in breast cancer	10
CRISPR-Cas knockout of miR21 reduces glioma growth	10
Noncoding RNA-mediated macrophage and cancer cell crosstalk in hepatocellular carcinoma	9
Carboranes as unique pharmacophores in antitumor medicinal chemistry	9
Improved oncolytic activity of a reovirus mutant that displays enhanced virus spread due to reduced cell attachment	9
Oncolytic measles vaccines encoding PD-1 and PD-L1 checkpoint blocking antibodies to increase tumor-specific T cell memory	9
Vaccinia virus and peptide-receptor radiotherapy synergize to improve treatment of peritoneal carcinomatosis	9
Exosomal and intracellular miR-320b promotes lymphatic metastasis in esophageal squamous cell carcinoma	9
Characterization of a novel OX40 ligand and CD40 ligand-expressing oncolytic adenovirus used in the PeptiCRAd cancer vaccine platform	9
Fluorescent imaging for cancer therapy and cancer gene therapy	9
Nucleic acids and proteins carried by exosomes of different origins as potential biomarkers for gynecologic cancers	9
Tumor-derived exosomal microRNA-7-5p enhanced by verbascoside inhibits biological behaviors of glioblastoma in vitro and in vivo	9
Efficacy of coxsackievirus A21 against drug-resistant neoplastic B cells	9
Molecular characterization of type I IFN-induced cytotoxicity in bladder cancer cells reveals biomarkers of resistance	9
Retraction Notice to: Exosomes Carrying MicroRNA-155 Target Forkhead Box O3 of Endothelial Cells and Promote Angiogenesis in Gastric Cancer	9
Gene knock-out chain reaction enables high disruption efficiency of HPV18 E6/E7 genes in cervical cancer cells	9
Targeting the lactic acid metabolic pathway for antitumor therapy	9
Ligand-based, piggyBac-engineered CAR-T cells targeting EGFR are safe and effective against non-small cell lung cancers	9
Characterization of the fatty acid metabolism in colorectal cancer to guide clinical therapy	9
The role of long non-coding RNAs in the pathogenesis of head and neck squamous cell carcinoma	9
Tumor microenvironment and immune-related therapies of head and neck squamous cell carcinoma	9
Redirecting anti-Vaccinia virus T cell immunity for cancer treatment by AAV-mediated delivery of the VV B8R gene	9
CCL18 promotes breast cancer progression by exosomal miR-760 activation of ARF6/Src/PI3K/Akt pathway	9
An epitope encoded by uORF of RNF10 elicits a therapeutic anti-tumor immune response	8
ENO1 and Cancer	8
Perturbing DDR signaling enhances cytotoxic effects of local oncolytic virotherapy and modulates the immune environment in glioma	8
Efficient antitumor effects of a novel oncolytic adenovirus fully composed of species B adenovirus serotype 35	8
Fascin actin-bundling protein 1 in human cancer: Promising biomarker or therapeutic target?	8
Cancer imaging and therapy utilizing a novel NIS-expressing adenovirus: The role of adenovirus death protein deletion	8
IL-13Rα2 humanized scFv-based CAR-T cells exhibit therapeutic activity against glioblastoma	8
RUNX1/EGFR pathway contributes to STAT3 activation and tumor growth caused by hyperactivated mTORC1	8
Angiogenesis-related non-coding RNAs and gastrointestinal cancer	8
Selective sodium iodide symporter (NIS) gene therapy of glioblastoma mediated by EGFR-targeted lipopolyplexes	8
Scutellarin resensitizes oxaliplatin-resistant colorectal cancer cells to oxaliplatin treatment through inhibition of PKM2	8
Development of a low-seroprevalence, αvβ6 integrin-selective virotherapy based on human adenovirus type 10	8
JNTX-101, a novel albumin-encapsulated gemcitabine prodrug, is efficacious and operates via caveolin-1-mediated endocytosis	8
UXT, a novel DNMT3b-binding protein, promotes breast cancer progression via negatively modulating lncRNA MEG3/p53 axis	8
Cardamonin suppresses pro-tumor function of macrophages by decreasing M2 polarization on ovarian cancer cells via mTOR inhibition	8
R-2HG downregulates ERα to inhibit cholangiocarcinoma via the FTO/m6A-methylated ERα/miR16-5p/YAP1 signal pathway	8
A novel PD-L1-targeted shark VNAR single-domain-based CAR-T cell strategy for treating breast cancer and liver cancer	8
Oncolytic Urabe mumps virus: A promising virotherapy for triple-negative breast cancer	8